Retatrutide
Price range: 20.000,00 EGP through 50.000,00 EGP
Retatrutide is a novel therapeutic agent currently under investigation for its potential efficacy in the treatment of metabolic disorders. Early clinical trials suggest that it may significantly impact weight management and glucose regulation in affected populations. As research progresses, comprehensive evaluation of its safety and effectiveness will be paramount to determining its role in clinical practice. The ongoing studies aim to elucidate the full range of benefits and risks associated with this promising compound. Next-generation GLP-3 weight-loss peptide. May support up to 20-25% body-weight loss.
Description
What It Is
Retatrutide is a next-generation GLP-3 weight-loss peptide that mimics GLP-1, GIP, and glucagon simultaneously to control appetite, improve metabolism, and burn fat. It is the most advanced weight-loss peptide currently available.
Best For
- Significant weight loss, especially stubborn visceral fat
- Patients who did not respond to semaglutide or tirzepatide
- Insulin resistance or prediabetes
- Users wanting strong appetite control with fewer side effects
Key Benefits
- May lead to 20โ25% body-weight loss
- Reduces visceral fat
- Improves metabolic health markers
- Increases energy and reduces brain fog
Dosage Protocol
Beginner: 1โ2 mg once weekly
Common: 4โ8 mg once weekly with slow titration every 4 weeks
Advanced: Up to 12 mg weekly if tolerated
Included With Every Order
โ Reconstitution solution, reconstitution syringe, and administration syringes included at no extra charge.
For research purposes only. Consult a qualified healthcare professional before use.
Additional information
| Size | 60mg, 20mg |
|---|




